Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300107
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,495
Award facts
- Contract value 100% obligated
- $10,495.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was made by the Office of the Director, a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $10,495.25 Firm Fixed Price contract is a Blanket Purchase Agreement (BPA) Call, with a ceiling value of $10,495.25 and an ultimate completion date of December 31, 2012. The contract is for DRUGS AND BIOLOGICALS and does not have a set-aside designation, indicating Roche Diagnostics competed openly for the award.
Roche Diagnostics holds multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across federal agencies, including a $37 million BPA with the Defense Health Agency for immunochemistry and clinical chemistry testing, and several Department of Veterans Affairs (VA) IDCs with ceiling values ranging from $208,000 to $3.1 million. These contract vehicles enable federal agencies to efficiently acquire Roche's medical diagnostic technologies through pre-negotiated pricing and terms, supporting healthcare delivery across military, veterans, and civilian healthcare systems.
Quick answers
Who was awarded contract HHSN26300107?
HHSN26300107 was awarded to Roche Diagnostics Corporation by Office of the Director (National Institutes of Health) on June 27, 2012.
How much is contract HHSN26300107 worth?
The government has obligated $10,495 on HHSN26300107.
Is contract HHSN26300107 an order under another contract?
Yes. HHSN26300107 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN26300107 competed?
The extent of competition for HHSN26300107 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award